C. Blake Gilks

Vancouver Coastal Health — Canada

Medicine · Health Sciences

80h-index23.5kcitations228works7.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(108), Endometrial and Cervical Cancer Treatments(59), Genetic factors in colorectal cancer(19), HER2/EGFR in Cancer Research(18), Cancer Genomics and Diagnostics(18)

Publications226 total

Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma Is Associated With Poor Clinical Outcomes in a Canadian Cohort
Modern Pathology·2025
Assessment of Nectin4-Expression in Vulvar Squamous Cell Carcinomas (Vscc): Correlation with Hpv-Associated and Hpv-Independent Molecular Subtypes
SSRN Electronic Journal·2025Open Access
Typing of Vulvar Squamous Cell Carcinoma: Why it is Important?
Advances in Anatomic Pathology·2024· 2 cited
AI-based histopathology image analysis reveals a distinct subset of endometrial cancers
Nature Communications·2024· 26 citedOpen Access
Tumors of the Ovary and Fallopian Tube
American Registry of PathologyArlington, Virginia eBooks·2023· 6 cited
To the editor
Gynecologic Oncology·2023
Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol
International Journal of Gynecological Pathology·2022· 26 cited
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
npj Precision Oncology·2022· 27 citedOpen Access
OP008/#194 P53ABN molecular subtype encompasses a morphologically diverse subset of endometrial cancers and identifies therapeutic opportunities to improve outcomes
2021· 2 citedOpen Access
Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer
Molecular Pharmaceutics·2021· 6 cited
Corded and Hyalinized and Spindled Endometrioid Endometrial Carcinoma
The American Journal of Surgical Pathology·2021· 27 cited
Survey on Reporting of Endometrial Biopsies From Women on Progestogen Therapy for Endometrial Atypical Hyperplasia/Endometrioid Carcinoma
International Journal of Gynecological Pathology·2021· 6 citedOpen Access
Evaluation of treatment effects in patients with endometrial cancer and <i>POLE</i> mutations: An individual patient data meta‐analysis
Cancer·2021· 144 citedOpen Access
p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification
International Journal of Gynecological Cancer·2021· 96 cited
Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists
International Journal of Gynecological Pathology·2021· 13 citedOpen Access
Abstract IA002: Histopathological classification of endometrial cancers and surrogate markers of genomic subtypes
Clinical Cancer Research·2021
Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines
Gynecologic Oncology·2020· 45 citedOpen Access
Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line
PLoS ONE·2020· 5 citedOpen Access
Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome
Modern Pathology·2020· 64 cited
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
Modern Pathology·2020· 38 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

David G. Huntsman(24), Steve E. Kalloger(11), Jessica N. McAlpine(11), Martin Köbel(9), Torsten O. Nielsen(8), Matt van de Rijn(8), Samuel Leung(7), Janine Senz(6), Maggie C.U. Cheang(5), Blaise Clarke(5), Stefan Kommoss(5), Melissa K. McConechy(5), Anthony N. Karnezis(5), Winnie Yang(5), Aline Talhouk(5), Forrest D. Hsu(4), Erika Yorida(4), David D.L. Bowtell(4), Robert B. West(4), Sohrab P. Shah(3)